New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.
about
Combination inhaled corticosteroids and long-acting beta 2 -agonists for children and adults with bronchiectasisCombination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasisA novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulationThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsG protein-coupled receptors in cardiac biology: old and new receptorsRole for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma.β-Agonist-mediated relaxation of airway smooth muscle is protein kinase A-dependent.Quantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways.For the love of paradox: from neurobiology to pharmacologyDefective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe AsthmaLong-Acting Beta Agonists Enhance Allergic Airway DiseaseGenetic Deletion of β-Arrestin-2 and the Mitigation of Established Airway Hyperresponsiveness in a Murine Asthma ModelChronic treatment in vivo with β-adrenoceptor agonists induces dysfunction of airway β(2) -adrenoceptors and exacerbates lung inflammation in mice.A-kinase anchoring proteins regulate compartmentalized cAMP signaling in airway smooth muscle.β-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway.Antimitogenic effect of bitter taste receptor agonists on airway smooth muscle cells.Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics.β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.Adrenergic regulation of IgE involves modulation of CD23 and ADAM10 expression on exosomesβ2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro.Novel cAMP signalling paradigms: therapeutic implications for airway diseaseRegulation of β-adrenergic receptor function: an emphasis on receptor resensitization.cAMP regulation of airway smooth muscle function.G-protein coupled receptor resensitization-appreciating the balancing act of receptor function.Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.GPCRs and arrestins in airways: implications for asthma.Ligand bias prevents class equality among beta-blockers.A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases.β2 AgonistsBronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.Far from "disappointing".Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout MiceThe intrinsic bias of generalizations.Special issue of BJP on respiratory pharmacology.Real time analysis of β(2)-adrenoceptor-mediated signaling kinetics in human primary airway smooth muscle cells reveals both ligand and dose dependent differences.Reply: Adverse effects of long-acting beta-agonists on airway hyperresponsiveness.Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines.
P2860
Q24194043-D4AC38BF-DF92-4D62-BD18-8C610E6F46B7Q24202012-1DAF16F7-7789-4B6F-9960-22B7FC98CD03Q28258154-4CEE1988-EB4B-410C-A2C6-4E462D5A561AQ30486707-51F57B02-2E25-4E0E-AFF9-F657AD34A5D7Q33639685-D05D87C0-E9E1-4ABD-AC4B-A58A5F80D900Q33975010-3D6A931D-853D-4ED0-8255-C63BCD4468A8Q34044729-9720E6B1-E8B0-4F4E-89D9-874E11CCC0B4Q35057786-D6CA957F-7379-48F4-B9B2-872CD6ADFE9BQ35163044-23F93708-1AFF-4057-8D9E-037AADD5AD64Q35645970-26F46F80-6346-4229-BBD0-148C383BD3E0Q35852118-4B53856B-2284-4C39-BA4B-2613AC1F6B78Q36049271-903F0C14-1E33-4D55-9A4D-0160A397E51EQ36147356-CA55A35E-3667-42B1-A05F-07E57B5A69E7Q36183699-6A0A4A6F-EA68-45EA-B2D9-53CD0B04D67BQ36339904-5E9EEB24-B5E8-4E19-B8B8-7353EEDE38A1Q36583856-F5747025-AFCB-492E-861E-7128A832F2C8Q36602201-59115798-4ABD-44C3-9ACC-00F564B700CAQ36703892-D8005123-61B0-4E23-B876-76948BF15FCEQ36744208-756E305B-9C27-4F37-939D-EA71E5E06C02Q37347126-2E0FD996-A6F7-4939-A649-C7D4DA9FB630Q37554447-F01DA964-540C-460C-8346-458791D92172Q37947662-498F800D-DDBE-40DA-9A33-D327783BD771Q37951309-F2A2AC00-8EC0-430E-8F50-20D8B2459FB7Q38013462-EC3AA9B0-B988-4F6F-87B6-9C7B0A12AE90Q38018652-4C0B4EAF-B01E-4251-A462-0B37348ABA40Q38166604-4E824824-0642-46A3-9DA3-310FDFA12F84Q38167643-B72138D5-EEC4-4B7D-B6E5-7C43280488D5Q38200427-698A299E-9B10-42E3-9176-90F1B66061DDQ38240756-02F7C812-8E39-40AF-8C4C-296F5F799B66Q38791742-36191534-0BA8-4BBC-A825-96B6022B0598Q38817408-DA1A779A-29C1-4FCC-BBE8-CBDD0A49B021Q38959067-1D6B7CE4-400E-436B-ABCD-48090B11C1A9Q39782286-4018CBE5-3B99-4639-BA6A-B05E5A965E56Q42346930-F23F2E6C-194E-457A-87B7-1D2D55A0B37DQ42368264-2EE5B574-5CDD-4382-9E43-F1CB7FAD8673Q42372110-C575D001-3304-41B7-9574-A4ED62E47C34Q42725432-DC8D4EE7-0C4E-401E-86E1-7932137F0EDAQ42839797-0DE5FD13-87EA-452E-ABDA-31BBE2077903Q42912763-98F42B73-C6A3-4126-9263-E03EF5ACB2DFQ47435365-4BBE27F6-D774-4BFE-A7B7-E4074D6F6281
P2860
New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New perspectives regarding β
@nl
New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.
@en
type
label
New perspectives regarding β
@nl
New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.
@en
prefLabel
New perspectives regarding β
@nl
New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.
@en
P2093
P2860
P1476
New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.
@en
P2093
B F Dickey
J K L Walker
N A Hanania
P2860
P356
10.1111/J.1476-5381.2010.01178.X
P407
P577
2011-05-01T00:00:00Z